Brief: Adocia announces two projects for the treatment of type 1 diabetes

Adocia SA

05/01/2017 17:01

Jan 5 (Reuters) - Adocia SA  ADOC.PA : 
    * Adocia announces two new multi-hormonal combination 
projects for the treatment of type 1 diabetes 
    * Medical benefit of such combinations already established 
in type 1 diabetes clinical trials with separate injections 
    * First clinical study expected to start in Q4 2017. 
    * New projects aim to offer more efficient therapy to people 
living with type 1 diabetes without increasing number of 
injections. 
    * Biochaperone enables combinations of insulin lispro with 
pramlintide and insulin lispro with exenatide, three hormones 
approved for treatment of diabetes 
 
Source text for Eikon:  ID:nBw62vGBfa  
Further company coverage:  ADOC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))